Correlation between quantitative-EEG alterations and age in patients with interferon-α-treated hepatitis C

Journal of Clinical Neurophysiology

Volumn 22, Issue 1, 2005, Pages 49-52

  Kamei, Satoshi ^a   Oga, Kentaro ^a,b   Matsuura, Masato ^a   Tanaka, Naohide ^a   Kojima, Takuya ^a   Arakawa, Yasuyuki ^a   Matsukawa, Yoshihiro ^a   Mizutani, Tomohiko ^a   Sakai, Teiichiro ^a   Ohkubo, Hitoshi ^a   Matsumura, Hiroshi ^a,b   Moriyama, Mitsuhiko ^a   Hirayanagi, Kaname ^a  

^a NIHON UNIVERSITY   (Japan)

^b Itabashi Med Association Hospital   (Japan)

Author keywords

Age of patient; Chronic hepatitis C; Interferon ; Quantitative EEG

Indexed keywords

ALPHA INTERFERON;

ADULT; AGE; AGED; ARTICLE; BRAIN FUNCTION; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG DOSE REGIMEN; EEG ABNORMALITY; ELECTROENCEPHALOGRAPHY; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; QUANTITATIVE ANALYSIS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION; ELECTROENCEPHALOGRAPHY; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MIDDLE AGED; NAPHTHALENES; OXEPINS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 19944432771     PISSN: 07360258     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.WNP.0000150889.77888.C4     Document Type: Article

References (6)

1. Kamei S, Tanaka N, Matsuura M, Arakawa Y, Kojima T, Matsukawa Y, Takasu T, Moriyama M. (1999) Blinded, prospective, and serial evaluation by quantitative-EEG in interferon-alpha-treated hepatitis-C. Acta Neurol Scand 100:25-33.
2. Kamei S, Sakai T, Matsuura M, Tanaka N, Kojima T, Arakawa Y, Matsukawa Y, Mizutani T, Oga K, Ohkubo H, Matsumura H, Hirayanagi K. (2002) Alterations of quantitative EEG and Mini-Mental State Examination in interferon-α-treated hepatitis C. Eur Neurol 48:102-7.
3. Meyers CA, Scheibel RS, Forman AD. (1991) Persistent neurotoxicity of systemically administered interferon-alpha. Neurology 41:672-6.
4. Rohatiner AZS, Prior PF, Burton AC, Smith AT, Balkwill FR, Lister TA. (1983) Central nervous system toxicity of interferon. Br J Cancer 47:419-22.
5. Saracco G, Rizzetto M. Therapy of chronic viral hepatitis. In: Bircher J, Benhamou J-P, McIntyre N, Rizzetto M, Rodés J, eds. Oxford textbook of clinical hepatology. Vol 1, 2nd ed. Oxford: Oxford University Press, 1999:939-54.
6. Smedley H, Kartrak M, Sikora K, Wheeler T. (1983) Neurological effects of recombinant interferon. BMJ 286:262-4.